Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of EUR 15.65 million. The enterprise value is 17.66 million.

Market Cap	15.65M
Enterprise Value	17.66M

Important Dates

The next estimated earnings date is Friday, December 27, 2024.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Theraclion has 46.03 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	46.03M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.51%
Owned by Institutions (%)	10.12%
Float	31.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.96
EV / Sales	13.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.67

Financial Position

The company has a current ratio of 4.82, with a Debt / Equity ratio of 2.41.

Current Ratio	4.82
Quick Ratio	3.50
Debt / Equity	2.41
Debt / EBITDA	n/a
Debt / FCF	-2.99
Interest Coverage	-121.92

Financial Efficiency

Return on equity (ROE) is -72.43% and return on invested capital (ROIC) is -14.09%.

Return on Equity (ROE)	-72.43%
Return on Assets (ROA)	-10.36%
Return on Capital (ROIC)	-14.09%
Revenue Per Employee	45,816
Profits Per Employee	-127,222
Employee Count	29
Asset Turnover	0.07
Inventory Turnover	0.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.00%
50-Day Moving Average	0.38
200-Day Moving Average	0.37
Relative Strength Index (RSI)	34.14
Average Volume (20 Days)	8,762

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theraclion had revenue of EUR 1.28 million and -3.56 million in losses.

Revenue	1.28M
Gross Profit	-1.78M
Operating Income	-2.96M
Pretax Income	-4.63M
Net Income	-3.56M
EBITDA	-3.28M
EBIT	-2.96M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 5.90 million in cash and 7.91 million in debt, giving a net cash position of -2.01 million or -0.04 per share.

Cash & Cash Equivalents	5.90M
Total Debt	7.91M
Net Cash	-2.01M
Net Cash Per Share	-0.04
Equity (Book Value)	3.28M
Book Value Per Share	n/a
Working Capital	9.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.57 million and capital expenditures -77,692, giving a free cash flow of -2.65 million.

Operating Cash Flow	-2.57M
Capital Expenditures	-77,692
Free Cash Flow	-2.65M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross margin is -139.01%, with operating and profit margins of -230.85% and -277.68%.

Gross Margin	-139.01%
Operating Margin	-230.85%
Pretax Margin	-361.07%
Profit Margin	-277.68%
EBITDA Margin	-255.29%
EBIT Margin	-230.85%
FCF Margin	-206.27%

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	-16.91%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theraclion has an Altman Z-Score of 1.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.06
Piotroski F-Score	n/a